Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/24/11/2808/16701430/mdt360.pdf
Reference20 articles.
1. Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade;Oberaigner;Acta Oncol,2012
2. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013
3. Surveillance Epidemiology and End Results (SEER) 2013 http://seer.cancer.gov/statfacts/html/ovary.html 4 February 2013, date last accessed
4. Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience;Thigpen;Cancer.,1993
5. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study;Freyer;Ann Oncol,2005
Cited by 103 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population;International Journal of Gynecologic Cancer;2024-09-03
2. Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial;Gynecologic Oncology;2024-08
3. First-line PARP inhibitor maintenance treatment in ovarian carcinoma for older adult women: a review of the current literature;Clinical and Translational Oncology;2024-07-19
4. Examining the impact of age on chemotherapy completion in epithelial ovarian, fallopian tube and primary peritoneal cancer: a retrospective cohort study in Thailand;BMJ Open;2024-07
5. Effect of different treatment modalities on the prognosis of stage IV epithelial ovarian cancer: analysis of the SEER database;BMC Women's Health;2024-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3